Sidley Represents BioRender in Investment Valuing Company at $900 Million

Sidley represented BioRender, a scientific communication platform with the mission of accelerating the world’s ability to learn, discover, and communicate science, in connection with a strategic investment from Dimension Capital that values the company at approximately $900 million.  As part of the transaction, BioRender provided liquidity to its employees.

The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital), and included Chloe Kaufman and Celine Gruaz (Emerging Companies and Venture Capital); Nicholas Frey (Employee Benefits and Executive Compensation); and Jonathan Westreich (Tax).